The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
The effectiveness of GnRHa with and without ‘add‐back’ therapy in treating premenstrual syndrome: a meta analysis
Abstract
Objective To determine the effectiveness of gonadotrophin‐releasing hormone analogues (GnRHa) with and without hormonal add‐back therapy in the management of premenstrual syndrome. Design Randomised controlled trials were identified by searching multiple databases. Setting Exeter and North Devon Research and Development Support Unit and Keele University Academic Unit of Obstetrics and Gynaecology. Population Women with pre‐diagnosed premenstrual syndrome and/or premenstrual dysphoric disorder. Methods A meta‐analysis of published randomised placebo‐controlled trials assessing the use of GnRHa in the management of premenstrual syndrome. The standardised mean difference for each individual study and subsequently an overall standardised mean difference were calculated after demonstrating the consistency or homogeneity of the study results. Main outcome measures Overall improvement in premenstrual symptomatology and effectiveness of GnRHa with additional hormonal add‐back therapy were the main outcome measures assessed in this analysis. A secondary analysis was performed to assess the effectiveness of GnRHa in treating physical and emotional symptoms. Results Overall standardised mean difference for all trials that assessed the efficacy of GnRHa was −1.19 (95% confidence interval [CI] −1.88 to −0.51). The equivalent odds ratio was 8.66 (95% CI 2.52 to 30.26) in favour of GnRHa. GnRHa were more efficacious for physical than behavioural symptoms, although the difference was not statistically significant. The addition of hormonal add‐back therapy to GnRHa did not appear to reduce the efficacy of GnRHa alone; standardised mean difference 0.12 (95% CI −0.35 to 0.58). Conclusions GnRHa appear to be an effective treatment in the management of premenstrual syndrome. The addition of hormonal add‐back therapy to reduce side effects does not reduce efficacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schmidt, P. J., Nieman, L. K., Danaceau, M. A., Adams, L. F., & Rubinow, D. R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801223380401 · Cited by 765
Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: A systematic review
Dimmock, P. W., Wyatt, K. M., Jones, P. W., & O'Brien, P. S. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02754-9 · Cited by 368 · cited 2×
“The effect appears comparable with that seen for selective serotonin reuptake inhibitors.(6) Progesterone, progestogens and the SSRI, fluoxetine, are all licensed for the management of premenstrual syndrome or premenstrual dysphoric disorder but no GnRH agonist is licensed.”
BackgroundSelf-citationEfficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review
Wyatt, K., Dimmock, P., Jones, P., Obhrai, M., & O'Brien, S. (2001) · BMJ · doi:10.1136/bmj.323.7316.776 · Cited by 168
Self-citation
Cited by
Management of functional somatic syndromes
Henningsen, P., Zipfel, S., & Herzog, W. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60159-7 · Cited by 741
Yonkers, K. A., O'Brien, P. S., & Eriksson, E. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60527-9 · Cited by 541
Self-citationPremenstrual dysphoric disorder: Evidence for a new category for DSM-5
Epperson, C. N., Steiner, M., Hartlage, S. A., Eriksson, E., Schmidt, P. J., Jones, I., & Yonkers, K. A. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.11081302 · Cited by 361
Premenstrual Dysphoric Disorder: Epidemiology and Treatment
Hantsoo, L., & Epperson, C. N. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0628-3 · Cited by 329
Yonkers, K. A., & Simoni, M. K. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.05.045 · Cited by 323
Metadata
- Authors
- Wyatt, K. M., Dimmock, P. W., Ismail, K. M. K., Jones, P. W., & O'Brien, P. M. S.
- Venue
- BJOG: An International Journal of Obstetrics & Gynaecology
- Publisher
- Wiley
- Published
- 2004-05-17
- Volume
- 111
- Issue
- 6
- Pages
- 585-593
- ISSN
- 0306-5456 (ISSN-L)
- 1470-0328
- 1471-0528
- OpenAlex
- W2032019275
- Cited by
- 189
- References
- 3
- FWCI
- 6.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The effectiveness of GnRHa with and without ‘add‐back’ therapy in treating premenstrual syndrome: a meta analysis. https://app.cochat.ai/papers/10.1111/j.1471-0528.2004.00135.x
- The paper
- Wyatt, K. M., Dimmock, P. W., Ismail, K. M. K., Jones, P. W., & O'Brien, P. M. S. (2004). The effectiveness of GnRHa with and without ‘add‐back’ therapy in treating premenstrual syndrome: a meta analysis. BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/j.1471-0528.2004.00135.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.